{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:42:50Z","timestamp":1784547770429,"version":"3.55.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82404173"],"award-info":[{"award-number":["82404173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu Province Foundation","award":["BK20240296"],"award-info":[{"award-number":["BK20240296"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10495-025-02207-9","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T09:33:24Z","timestamp":1768037604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Programmed cell death of keratinocytes: an active driver in psoriasis"],"prefix":"10.1007","volume":"31","author":[{"given":"Tianyi","family":"Yuwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-8116","authenticated-orcid":false,"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"2207_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN (2021) Psoriasis. Lancet 397:1301\u20131315","journal-title":"Lancet"},{"key":"2207_CR2","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/1523-1747.ep12520022","volume":"76","author":"JA Parrish","year":"1981","unstructured":"Parrish JA, Jaenicke KF (1981) Action spectrum for phototherapy of psoriasis. J Invest Dermatol 76:359\u2013362","journal-title":"J Invest Dermatol"},{"key":"2207_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/JLB.5MR0120-439R","volume":"108","author":"XH Ni","year":"2020","unstructured":"Ni XH, Lai YP (2020) Keratinocyte: a trigger or an executor of psoriasis? J Leukoc Biol 108:485\u2013491","journal-title":"J Leukoc Biol"},{"key":"2207_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nature00820","volume":"417","author":"M Pasparakis","year":"2002","unstructured":"Pasparakis M, Courtois G, Hafner M et al (2002) TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417:861\u2013866","journal-title":"Nature"},{"key":"2207_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature03963","volume":"437","author":"R Zenz","year":"2005","unstructured":"Zenz R, Eferl R, Kenner L et al (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437:369","journal-title":"Nature"},{"key":"2207_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000495291","volume":"235","author":"F Benhadou","year":"2019","unstructured":"Benhadou F, Mintoff D, Del Marmol V (2019) Psoriasis: keratinocytes or immune cells\u2014which is the trigger? Dermatology 235:91\u2013100","journal-title":"Dermatology"},{"key":"2207_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R et al (2022) Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther 7:286","journal-title":"Signal Transduct Target Ther"},{"key":"2207_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nri.2016.153","volume":"17","author":"S Nagata","year":"2017","unstructured":"Nagata S, Tanaka M (2017) Programmed cell death and the immune system. Nat Rev Immunol 17:333\u2013340","journal-title":"Nat Rev Immunol"},{"key":"2207_CR9","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00018-016-2209-y","volume":"73","author":"L Galluzzi","year":"2016","unstructured":"Galluzzi L, Pedro JMB-S, Kepp O, Kroemer G (2016) Regulated cell death and adaptive stress responses. Cell Mol Life Sci 73:2405\u20132410","journal-title":"Cell Mol Life Sci"},{"key":"2207_CR10","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1042\/BCJ20210606","volume":"479","author":"H Anderton","year":"2022","unstructured":"Anderton H, Alqudah S (2022) Cell death in skin function, inflammation, and disease. Biochem J 479:1621\u20131651","journal-title":"Biochem J"},{"key":"2207_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-023-01566-z","volume":"9","author":"YH Han","year":"2023","unstructured":"Han YH, Feng L, Lee SJ et al (2023) Depletion of peroxiredoxin II promotes keratinocyte apoptosis and alleviates psoriatic skin lesions via the PI3K\/AKT\/GSK3\u03b2 signaling axis. Cell Death Discov 9:263","journal-title":"Cell Death Discov"},{"key":"2207_CR12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191913","volume":"217","author":"M Devos","year":"2020","unstructured":"Devos M, Tanghe G, Gilbert B et al (2020) Sensing of endogenous nucleic acids by ZBP1 induces keratinocyte necroptosis and skin inflammation. J Exp Med 217:e20191913","journal-title":"J Exp Med"},{"key":"2207_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s12276-021-00634-7","volume":"53","author":"J Seo","year":"2021","unstructured":"Seo J, Nam YW, Kim S, Oh DB, Song J (2021) Necroptosis molecular mechanisms: recent findings regarding novel necroptosis regulators. Exp Mol Med 53:1007\u20131017","journal-title":"Exp Mol Med"},{"key":"2207_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1019447","volume":"9","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Yang L, Li T et al (2022) Mechanisms and inhibitors of ferroptosis in psoriasis. Front Mol Biosci 9:1019447","journal-title":"Front Mol Biosci"},{"key":"2207_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06094-3","volume":"14","author":"N Lian","year":"2023","unstructured":"Lian N, Chen Y, Chen S et al (2023) Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis. Cell Death Dis 14:595","journal-title":"Cell Death Dis"},{"key":"2207_CR16","doi-asserted-by":"publisher","first-page":"1286344","DOI":"10.3389\/fimmu.2023.1286344","volume":"14","author":"M Kamata","year":"2023","unstructured":"Kamata M, Tada Y (2023) Crosstalk: keratinocytes and immune cells in psoriasis. Front Immunol 14:1286344","journal-title":"Front Immunol"},{"key":"2207_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/jid.2008.194","volume":"129","author":"LC Zaba","year":"2009","unstructured":"Zaba LC, Fuentes-Duculan J, Eungdamrong NJ et al (2009) Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 129:79\u201388","journal-title":"J Invest Dermatol"},{"key":"2207_CR18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ni.1613","volume":"9","author":"E Volpe","year":"2008","unstructured":"Volpe E, Servant N, Zollinger R et al (2008) A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 9:650\u2013657","journal-title":"Nat Immunol"},{"key":"2207_CR19","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910\u20131914","journal-title":"J Biol Chem"},{"key":"2207_CR20","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1084\/jem.20071094","volume":"204","author":"LC Zaba","year":"2007","unstructured":"Zaba LC, Cardinale I, Gilleaudeau P et al (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183\u20133194","journal-title":"J Exp Med"},{"key":"2207_CR21","first-page":"949","volume":"113","author":"N Novak","year":"2004","unstructured":"Novak N, Valenta R, Bohle B et al (2004) FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 113:949\u2013957","journal-title":"J Allergy Clin Immunol"},{"key":"2207_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12964-022-00995-0","volume":"20","author":"B-X Yan","year":"2022","unstructured":"Yan B-X, Chen X-Y, Wang Z-Y et al (2022) Mupirocin blocks imiquimod-induced psoriasis-like skin lesion by inhibiting epidermal isoleucyl-tRNA synthetase. Cell Commun Signal 20:185","journal-title":"Cell Commun Signal"},{"key":"2207_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.07.041","volume":"623","author":"L Liu","year":"2022","unstructured":"Liu L, Kang X-x (2022) ACSL4 is overexpressed in psoriasis and enhances inflammatory responses by activating ferroptosis. Biochem Biophys Res Commun 623:1\u20138","journal-title":"Biochem Biophys Res Commun"},{"key":"2207_CR24","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.922035","volume":"26","author":"A Krawczyk","year":"2020","unstructured":"Krawczyk A, Mi\u015bkiewicz J, Strzelec K, Wcis\u0142o-Dziadecka D, Strzalka-Mrozik B (2020) Apoptosis in autoimmunological diseases, with particular consideration of molecular aspects of psoriasis. Med Sci Monit 26:e922035","journal-title":"Med Sci Monit"},{"key":"2207_CR25","first-page":"439","volume":"60","author":"K\u0141 Grzanka","year":"2006","unstructured":"Grzanka K\u0141, Izdebska M (2006) Mitochondria and cell death. Postpy Higieny I Medycyny Dowiadczalnej 60:439","journal-title":"Postpy Higieny I Medycyny Dowiadczalnej"},{"key":"2207_CR26","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nrm2952","volume":"11","author":"SW Tait","year":"2010","unstructured":"Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11:621\u2013632","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2207_CR27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008706","volume":"5","author":"SWG Tait","year":"2013","unstructured":"Tait SWG, Green DR (2013) Mitochondrial regulation of cell death. Cold Spring Harb Perspect Biol 5:9","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2207_CR28","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.tcb.2016.07.002","volume":"26","author":"MPA Luna-Vargas","year":"2016","unstructured":"Luna-Vargas MPA, Chipuk JE (2016) Physiological and pharmacological control of BAK, BAX, and beyond. Trends Cell Biol 26:906\u2013917","journal-title":"Trends Cell Biol"},{"key":"2207_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.tcb.2012.10.010","volume":"23","author":"A Aouacheria","year":"2013","unstructured":"Aouacheria A, Valentine RDL, Combet C, Hardwick JM (2013) Evolution of Bcl-2 homology motifs: homology versus homoplasy. Trends Cell Biol 23:103\u2013111","journal-title":"Trends Cell Biol"},{"key":"2207_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc.2015.17","volume":"16","author":"AR Delbridge","year":"2016","unstructured":"Delbridge AR, Grabow S, Strasser A, Vaux DL (2016) Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer 16:99\u2013109","journal-title":"Nat Rev Cancer"},{"key":"2207_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/embor.2012.19","volume":"13","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G (2012) Non-apoptotic functions of apoptosis-regulatory proteins. EMBO Rep 13:322\u2013330","journal-title":"EMBO Rep"},{"key":"2207_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0092-8674(00)80849-1","volume":"101","author":"K Li","year":"2000","unstructured":"Li K, Li Y, Shelton JM et al (2000) Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis\u2014sciencedirect. Cell 101:389\u2013399","journal-title":"Cell"},{"key":"2207_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/35022514","volume":"406","author":"J Chai","year":"2000","unstructured":"Chai J, Du C, Wu JW, Kyin S, Shi Y (2000) Structural and biochemical basis of apoptotic activation by Smac\/DIABLO. Nature 406:855\u2013862","journal-title":"Nature"},{"key":"2207_CR34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479\u2013489","journal-title":"Cell"},{"key":"2207_CR35","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/cdd.2017.44","volume":"24","author":"O Julien","year":"2017","unstructured":"Julien O, Wells JA (2017) Caspases and their substrates. Cell Death Differ 24:1380\u20131389","journal-title":"Cell Death Differ"},{"key":"2207_CR36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/cdd.2014.216","volume":"22","author":"S Shalini","year":"2015","unstructured":"Shalini S, Dorstyn L, Dawar S, Kumar S (2015) Old, new and emerging functions of caspases. Cell Death Differ 22:526\u2013539","journal-title":"Cell Death Differ"},{"key":"2207_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15:49\u201363","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2207_CR38","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","volume":"24","author":"PE Czabotar","year":"2023","unstructured":"Czabotar PE, Garcia-Saez AJ (2023) Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat Rev Mol Cell Biol 24:732\u2013748","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2207_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA et al (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25:486\u2013541","journal-title":"Cell Death Differ"},{"key":"2207_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.tcb.2015.03.003","volume":"25","author":"DA Flusberg","year":"2015","unstructured":"Flusberg DA, Sorger PK (2015) Surviving apoptosis: life-death signaling in single cells. Trends Cell Biol 25:446\u2013458","journal-title":"Trends Cell Biol"},{"key":"2207_CR41","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1158\/0008-5472.CAN-14-3652","volume":"75","author":"B Gibert","year":"2015","unstructured":"Gibert B, Mehlen P (2015) Dependence receptors and cancer: addiction to trophic ligands. Cancer Res 75:5171\u20135175","journal-title":"Cancer Res"},{"key":"2207_CR42","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","volume":"281","author":"A Ashkenazi","year":"1998","unstructured":"Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305\u20131308","journal-title":"Science"},{"key":"2207_CR43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","volume":"30","author":"A Strasser","year":"2009","unstructured":"Strasser A, Jost PJ, Nagata S (2009) The many roles of FAS receptor signaling in the immune system. Immunity 30:180\u2013192","journal-title":"Immunity"},{"key":"2207_CR44","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1126\/science.1071553","volume":"296","author":"H Wajant","year":"2002","unstructured":"Wajant H (2002) The Fas signaling pathway: more than a paradigm. Science 296:1635","journal-title":"Science"},{"key":"2207_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrc.2017.28","volume":"17","author":"S Von Karstedt","year":"2017","unstructured":"Von Karstedt S, Montinaro A, Walczak H (2017) Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy. Nat Rev Cancer 17:352\u2013366","journal-title":"Nat Rev Cancer"},{"key":"2207_CR46","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","volume":"18","author":"D Bertheloot","year":"2021","unstructured":"Bertheloot D, Latz E, Franklin BS (2021) Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol 18:1106\u20131121","journal-title":"Cell Mol Immunol"},{"key":"2207_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/sj.jid.5700008","volume":"126","author":"D Raj","year":"2006","unstructured":"Raj D, Brash DE, Grossman D (2006) Keratinocyte apoptosis in epidermal development and disease. J Invest Dermatol 126:243\u2013257","journal-title":"J Invest Dermatol"},{"key":"2207_CR48","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1101\/cshperspect.a006049","volume":"4","author":"K Newton","year":"2012","unstructured":"Newton K, Dixit VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4:829\u2013841","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2207_CR49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","volume":"69","author":"AM Goldminz","year":"2013","unstructured":"Goldminz AM, Au SC, Kim N, Gottlieb AB, Lizzul PF (2013) NF-\u03baB: an essential transcription factor in psoriasis. J Dermatol Sci 69:89\u201394","journal-title":"J Dermatol Sci"},{"key":"2207_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","volume":"11","author":"S Thatikonda","year":"2020","unstructured":"Thatikonda S, Pooladanda V, Sigalapalli DK, Godugu C (2020) Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation. Cell Death Dis 11:21","journal-title":"Cell Death Dis"},{"key":"2207_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0923-1811(01)00162-1","volume":"28","author":"H Takahashi","year":"2002","unstructured":"Takahashi H, Manabe A, Ishida-Yamamoto A, Hashimoto Y, Iizuka H (2002) Aberrant expression of apoptosis-related molecules in psoriatic epidermis. J Dermatol Sci 28:187\u2013197","journal-title":"J Dermatol Sci"},{"key":"2207_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10495-020-01623-3","volume":"25","author":"B Wang","year":"2020","unstructured":"Wang B, Han D, Li F et al (2020) Elevated IL-22 in psoriasis plays an anti-apoptotic role in keratinocytes through mediating Bcl-xL\/Bax. Apoptosis 25:663\u2013673","journal-title":"Apoptosis"},{"key":"2207_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12938-021-00943-y","volume":"20","author":"X Sun","year":"2021","unstructured":"Sun X, Yang P (2021) Inhibition of BRD4 inhibits proliferation and promotes apoptosis of psoriatic keratinocytes. Biomed Eng Online 20:107","journal-title":"Biomed Eng Online"},{"key":"2207_CR54","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.4103\/0366-6999.239297","volume":"131","author":"LW Ran","year":"2018","unstructured":"Ran LW, Wang H, Lan D, Jia HX, Yu SS (2018) Effect of RNA interference targeting STAT3 gene combined with ultrasonic irradiation and SonoVue microbubbles on proliferation and apoptosis in keratinocytes of psoriatic lesions. Chin Med J (Engl) 131:2097\u20132104","journal-title":"Chin Med J (Engl)"},{"key":"2207_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms19010171","volume":"19","author":"E Calautti","year":"2018","unstructured":"Calautti E, Avalle L, Poli V (2018) Psoriasis: A STAT3-Centric View. Int J Mol Sci 19:171","journal-title":"Int J Mol Sci"},{"key":"2207_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nm1162","volume":"11","author":"S Sano","year":"2005","unstructured":"Sano S, Chan KS, Carbajal S et al (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43\u201349","journal-title":"Nat Med"},{"key":"2207_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdermsci.2007.05.016","volume":"50","author":"S Sano","year":"2008","unstructured":"Sano S, Chan KS, DiGiovanni J (2008) Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 50:1\u201314","journal-title":"J Dermatol Sci"},{"key":"2207_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175276","volume":"933","author":"J Tang","year":"2022","unstructured":"Tang J, Liu C, Liu S et al (2022) Inhibition of JAK1\/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model. Eur J Pharmacol 933:175276","journal-title":"Eur J Pharmacol"},{"key":"2207_CR59","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.bbrc.2005.03.189","volume":"331","author":"J Yu","year":"2005","unstructured":"Yu J, Zhang L (2005) The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 331:851\u2013858","journal-title":"Biochem Biophys Res Commun"},{"key":"2207_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400107","volume":"11","author":"N Wang","year":"2024","unstructured":"Wang N, Xu X, Guan F et al (2024) FGF12 positively regulates keratinocyte proliferation by stabilizing MDM2 and inhibiting p53 activity in psoriasis. Adv Sci (Weinh) 11:e2400107","journal-title":"Adv Sci (Weinh)"},{"key":"2207_CR61","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s12033-024-01211-9","volume":"67","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhu C, Tai Z, Lian T, Zhu Q, Chen Z (2025) Cordycepin ameliorates psoriasis-like skin lesion by regulating p53\/MDM2 feedback loop. Mol Biotechnol 67:2481\u20132492","journal-title":"Mol Biotechnol"},{"key":"2207_CR62","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/jid.2011.134","volume":"131","author":"SC Weatherhead","year":"2011","unstructured":"Weatherhead SC, Farr PM, Jamieson D et al (2011) Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation. J Invest Dermatol 131:1916\u20131926","journal-title":"J Invest Dermatol"},{"key":"2207_CR63","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1084\/jem.189.4.711","volume":"189","author":"M Ozawa","year":"1999","unstructured":"Ozawa M, Ferenczi K, Kikuchi T et al (1999) 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 189:711\u2013718","journal-title":"J Exp Med"},{"key":"2207_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101924","volume":"41","author":"R Addison","year":"2021","unstructured":"Addison R, Weatherhead SC, Pawitri A et al (2021) Therapeutic wavelengths of ultraviolet B radiation activate apoptotic, circadian rhythm, redox signalling and key canonical pathways in psoriatic epidermis. Redox Biol 41:101924","journal-title":"Redox Biol"},{"key":"2207_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/phpp.12012","volume":"29","author":"M El-Domyati","year":"2013","unstructured":"El-Domyati M, Moftah NH, Nasif GA, Abdel-Wahab HM, Barakat MT, Abdel-Aziz RT (2013) Evaluation of apoptosis regulatory proteins in response to PUVA therapy for psoriasis. Photodermatol Photoimmunol Photomed 29:18\u201326","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"2207_CR66","doi-asserted-by":"publisher","first-page":"e972","DOI":"10.1111\/j.1365-2230.2009.03518.x","volume":"34","author":"R Tiberio","year":"2009","unstructured":"Tiberio R, Bozzo C, Pertusi G et al (2009) Calcipotriol induces apoptosis in psoriatic keratinocytes. Clin Exp Dermatol 34:e972\u2013e974","journal-title":"Clin Exp Dermatol"},{"key":"2207_CR67","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1096\/fj.04-2664fje","volume":"19","author":"A McGill","year":"2005","unstructured":"McGill A, Frank A, Emmett N et al (2005) The antipsoriatic drug anthralin accumulates in keratinocyte mitochondria, dissipates mitochondrial membrane potential, and induces apoptosis through a pathway dependent on respiratory competent mitochondria. FASEB J 19:1012\u20131014","journal-title":"FASEB J"},{"key":"2207_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010267","volume":"18","author":"F Shmarov","year":"2022","unstructured":"Shmarov F, Smith GR, Weatherhead SC, Reynolds NJ, Zuliani P (2022) Individualised computational modelling of immune mediated disease onset, flare and clearance in psoriasis. PLoS Comput Biol 18:e1010267","journal-title":"PLoS Comput Biol"},{"key":"2207_CR69","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/bioinformatics\/btm042","volume":"23","author":"N Grabe","year":"2007","unstructured":"Grabe N, Neuber K (2007) Simulating psoriasis by altering transit amplifying cells. Bioinformatics 23:1309\u20131312","journal-title":"Bioinformatics"},{"key":"2207_CR70","doi-asserted-by":"publisher","first-page":"22103","DOI":"10.1038\/s41598-024-73746-5","volume":"14","author":"M Farahani","year":"2024","unstructured":"Farahani M, Robati RM, Rezaei-Tavirani M et al (2024) Integrating protein interaction and pathway crosstalk network reveals a promising therapeutic approach for psoriasis through apoptosis induction. Sci Rep 14:22103","journal-title":"Sci Rep"},{"key":"2207_CR71","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.18632\/aging.103045","volume":"12","author":"L Mercurio","year":"2020","unstructured":"Mercurio L, Lulli D, Mascia F et al (2020) Intracellular insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21. Aging 12:6823\u20136851","journal-title":"Aging"},{"key":"2207_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090284","volume":"9","author":"C Andrea","year":"2014","unstructured":"Andrea C, Nograles KE, Johnson-Huang LM et al (2014) IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model. PLoS ONE 9:e90284","journal-title":"PLoS ONE"},{"key":"2207_CR73","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","volume":"9","author":"A Cristina","year":"2018","unstructured":"Cristina A, Stefania M, Paolo G, Giampiero G (2018) The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis. Front Immunol 9:1549","journal-title":"Front Immunol"},{"key":"2207_CR74","doi-asserted-by":"publisher","first-page":"13831","DOI":"10.1038\/s41598-017-14365-1","volume":"7","author":"NN Mehta","year":"2017","unstructured":"Mehta NN, Teague HL, Swindell WR et al (2017) IFN-\u03b3 and TNF-\u03b1 synergism may provide a link between psoriasis and inflammatory atherogenesis. Sci Rep 7:13831","journal-title":"Sci Rep"},{"key":"2207_CR75","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1365-2133.2005.06508.x","volume":"152","author":"A Konur","year":"2005","unstructured":"Konur A, Schulz U, Eissner G, Andreesen R, Holler E (2005) Interferon (IFN)-\u03b3 is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-\u03b3 and tumour necrosis factor-\u03b1 production. Br J Dermatol 152:1134\u20131142","journal-title":"Br J Dermatol"},{"key":"2207_CR76","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jid.2023.09.270","volume":"144","author":"YX Zheng","year":"2024","unstructured":"Zheng YX, Chen XB, Xu F et al (2024) Glycyl-tRNA synthetase induces psoriasis-like skin by facilitating skin inflammation and vascular endothelial cell angiogenesis. J Invest Dermatol 144:774-785.e710","journal-title":"J Invest Dermatol"},{"key":"2207_CR77","first-page":"17","volume":"151","author":"G Caldarola","year":"2016","unstructured":"Caldarola G, Carbone A, Arena V et al (2016) Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL): a possible pathogenic role in chronic plaque psoriasis. G Ital Dermatol Venereol 151:17\u201324","journal-title":"G Ital Dermatol Venereol"},{"key":"2207_CR78","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.jaci.2010.03.018","volume":"125","author":"LC Zaba","year":"2010","unstructured":"Zaba LC, Fuentes-Duculan J, Eungdamrong NJ et al (2010) Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis. J Allergy Clin Immunol 125:1261\u20131268","journal-title":"J Allergy Clin Immunol"},{"key":"2207_CR79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jdermsci.2018.04.007","volume":"91","author":"N Saito","year":"2018","unstructured":"Saito N, Honma M, Shibuya T et al (2018) RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis. J Dermatol Sci 91:79\u201386","journal-title":"J Dermatol Sci"},{"key":"2207_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119689","volume":"1871","author":"Y Liang","year":"2024","unstructured":"Liang Y, Han D, Zhang S, Sun L (2024) FOSL1 regulates hyperproliferation and NLRP3-mediated inflammation of psoriatic keratinocytes through the NF-kB signaling via transcriptionally activating TRAF3. Biochim Biophys Acta Mol Cell Res 1871:119689","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"2207_CR81","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1023\/A:1025319031417","volume":"23","author":"A Bhardwaj","year":"2003","unstructured":"Bhardwaj A, Aggarwal BB (2003) Receptor-mediated choreography of life and death. J Clin Immunol 23:317\u2013332","journal-title":"J Clin Immunol"},{"key":"2207_CR82","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41419-023-06134-y","volume":"14","author":"Z Fang","year":"2023","unstructured":"Fang Z, Wang Y, Huang B, Chen X, Jiang R, Yin M (2023) Depletion of G9A attenuates imiquimod-induced psoriatic dermatitis via targeting EDAR-NF-\u03baB signaling in keratinocyte. Cell Death Dis 14:627","journal-title":"Cell Death Dis"},{"key":"2207_CR83","doi-asserted-by":"publisher","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","volume":"272","author":"Y Chicheportiche","year":"1997","unstructured":"Chicheportiche Y, Bourdon PR, Xu H et al (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis*. J Biol Chem 272:32401\u201332410","journal-title":"J Biol Chem"},{"key":"2207_CR84","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.4049\/jimmunol.178.12.8183","volume":"178","author":"LC Bover","year":"2007","unstructured":"Bover LC, Card\u00f3-Vila M, Kuniyasu A et al (2007) A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications1. J Immunol 178:8183\u20138194","journal-title":"J Immunol"},{"key":"2207_CR85","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/ijd.14646","volume":"59","author":"B Engin","year":"2020","unstructured":"Engin B, Tanakol A, Bulut H et al (2020) Changes in serum TNF-like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti-TNF treatments. Int J Dermatol 59:207\u2013215","journal-title":"Int J Dermatol"},{"key":"2207_CR86","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/exd.12820","volume":"25","author":"H Cheng","year":"2016","unstructured":"Cheng H, Xu MF, Liu XM, Zou XY, Zhan N, Xia YM (2016) TWEAK\/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation. Exp Dermatol 25:32\u201337","journal-title":"Exp Dermatol"},{"issue":"200\u2013207","key":"2207_CR87","first-page":"207.e201","volume":"127","author":"M Zimmermann","year":"2011","unstructured":"Zimmermann M, Koreck A, Meyer N et al (2011) TNF-like weak inducer of apoptosis (TWEAK) and TNF-\u03b1 cooperate in the induction of keratinocyte apoptosis. J Allergy Clin Immunol 127(200\u2013207):207.e201-210","journal-title":"J Allergy Clin Immunol"},{"key":"2207_CR88","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.jid.2017.05.031","volume":"137","author":"H Anderton","year":"2017","unstructured":"Anderton H, Rickard JA, Varigos GA, Lalaoui N, Silke J (2017) Inhibitor of Apoptosis Proteins (IAPs) limit RIPK1-mediated skin inflammation. J Invest Dermatol 137:2371\u20132379","journal-title":"J Invest Dermatol"},{"key":"2207_CR89","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jaad.2016.02.1221","volume":"75","author":"PS Yamauchi","year":"2016","unstructured":"Yamauchi PS, Bissonnette R, Teixeira HD, Valdecantos WC (2016) Systematic review of efficacy of anti\u2013tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti\u2013TNF agent. J Am Acad Dermatol 75:612-618.e616","journal-title":"J Am Acad Dermatol"},{"key":"2207_CR90","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM (2024) Cell death. Cell 187:235\u2013256","journal-title":"Cell"},{"key":"2207_CR91","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.molmed.2017.11.002","volume":"24","author":"A Annibaldi","year":"2017","unstructured":"Annibaldi A, Meier P (2017) Checkpoints in TNF-induced cell death: implications in inflammation and cancer. Trends Mol Med 24:49","journal-title":"Trends Mol Med"},{"key":"2207_CR92","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036376","volume":"12","author":"JM Murphy","year":"2020","unstructured":"Murphy JM (2020) The killer pseudokinase Mixed Lineage Kinase Domain-Like Protein (MLKL). Cold Spring Harb Perspect Biol 12:a036376","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2207_CR93","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature13608","volume":"513","author":"M Dannappel","year":"2014","unstructured":"Dannappel M, Vlantis K, Kumari S et al (2014) RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis. Nature 513:90\u201394","journal-title":"Nature"},{"key":"2207_CR94","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature20558","volume":"540","author":"J Lin","year":"2016","unstructured":"Lin J, Kumari S, Kim C et al (2016) RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. Nature 540:124\u2013128","journal-title":"Nature"},{"key":"2207_CR95","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jid.2017.10.013","volume":"138","author":"JE Hawkes","year":"2018","unstructured":"Hawkes JE, Adalsteinsson JA, Gudjonsson JE, Ward NL (2018) Research techniques made simple: murine models of human psoriasis. J Invest Dermatol 138:e1\u2013e8","journal-title":"J Invest Dermatol"},{"key":"2207_CR96","first-page":"72","volume":"39","author":"X Meng","year":"2022","unstructured":"Meng X, Guo R, Fan C et al (2022) RIPK1 downregulation enhances neutrophil extracellular traps in psoriasis. Postepy Dermatol Alergol 39:72\u201380","journal-title":"Postepy Dermatol Alergol"},{"key":"2207_CR97","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaci.2017.02.027","volume":"140","author":"T Honda","year":"2017","unstructured":"Honda T, Yamamoto O, Sawada Y et al (2017) Receptor-interacting protein kinase 3 controls keratinocyte activation in a necroptosis-independent manner and promotes psoriatic dermatitis in mice. J Allergy Clin Immunol 140:619-622.e616","journal-title":"J Allergy Clin Immunol"},{"key":"2207_CR98","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41419-024-06514-y","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Liu X, Liu Y et al (2024) Saracatinib inhibits necroptosis and ameliorates psoriatic inflammation by targeting MLKL. Cell Death Dis 15:122","journal-title":"Cell Death Dis"},{"key":"2207_CR99","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41418-019-0347-0","volume":"27","author":"S Patel","year":"2020","unstructured":"Patel S, Webster JD, Varfolomeev E et al (2020) RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases. Cell Death Differ 27:161\u2013175","journal-title":"Cell Death Differ"},{"key":"2207_CR100","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s41419-020-2328-0","volume":"11","author":"X Duan","year":"2020","unstructured":"Duan X, Liu X, Liu N et al (2020) Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation. Cell Death Dis 11:134","journal-title":"Cell Death Dis"},{"key":"2207_CR101","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1021\/acs.jmedchem.6b01751","volume":"60","author":"PA Harris","year":"2017","unstructured":"Harris PA, Berger SB, Jeong JU et al (2017) Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases. J Med Chem 60:1247\u20131261","journal-title":"J Med Chem"},{"key":"2207_CR102","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nchembio.83","volume":"4","author":"A Degterev","year":"2008","unstructured":"Degterev A, Hitomi J, Germscheid M et al (2008) Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol 4:313\u2013321","journal-title":"Nat Chem Biol"},{"key":"2207_CR103","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/cpt.1852","volume":"108","author":"K Weisel","year":"2020","unstructured":"Weisel K, Berger S, Papp K et al (2020) Response to inhibition of receptor-interacting protein kinase 1 (RIPK1) in active plaque psoriasis: a randomized placebo-controlled study. Clin Pharmacol Ther 108:808\u2013816","journal-title":"Clin Pharmacol Ther"},{"key":"2207_CR104","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s13555-024-01097-0","volume":"14","author":"VJ Ludbrook","year":"2024","unstructured":"Ludbrook VJ, Budd DC, Thorn K et al (2024) Inhibition of receptor-interacting protein kinase 1 in chronic plaque psoriasis: a multicenter, randomized, double-blind, placebo-controlled study. Dermatol Ther (Heidelb) 14:489\u2013504","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2207_CR105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz P, Pelegrin P, Shao F (2020) The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol 20:143\u2013157","journal-title":"Nat Rev Immunol"},{"key":"2207_CR106","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi M, Dixit VM (2014) Mechanisms and functions of inflammasomes. Cell 157:1013\u20131022","journal-title":"Cell"},{"key":"2207_CR107","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526:660\u2013665","journal-title":"Nature"},{"key":"2207_CR108","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coi.2015.01.007","volume":"32","author":"J Yang","year":"2015","unstructured":"Yang J, Zhao Y, Shao F (2015) Non-canonical activation of inflammatory caspases by cytosolic LPS in innate immunity. Curr Opin Immunol 32:78\u201383","journal-title":"Curr Opin Immunol"},{"key":"2207_CR109","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature13683","volume":"514","author":"J Shi","year":"2014","unstructured":"Shi J, Zhao Y, Wang Y et al (2014) Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514:187\u2013192","journal-title":"Nature"},{"key":"2207_CR110","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/ni.1613","volume":"9","author":"E Volpe","year":"2008","unstructured":"Volpe E, Servant N, Zollinger R et al (2008) A critical function for transforming growth factor-\u03b2, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat Immunol 9:650\u2013657","journal-title":"Nat Immunol"},{"key":"2207_CR111","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W et al (2016) Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535:111\u2013116","journal-title":"Nature"},{"key":"2207_CR112","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang ZB, Ruan JB et al (2016) Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535:153","journal-title":"Nature"},{"key":"2207_CR113","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F (2017) Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci 42:245\u2013254","journal-title":"Trends Biochem Sci"},{"key":"2207_CR114","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"YP Wang","year":"2017","unstructured":"Wang YP, Gao WQ, Shi XY et al (2017) Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547:99","journal-title":"Nature"},{"key":"2207_CR115","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.immuni.2023.04.001","volume":"56","author":"R Bharadwaj","year":"2023","unstructured":"Bharadwaj R, Lusi CF, Mashayekh S et al (2023) Methotrexate suppresses psoriatic skin inflammation by inhibiting muropeptide transporter SLC46A2 activity. Immunity 56:998-1012.e1018","journal-title":"Immunity"},{"key":"2207_CR116","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/bjd\/ljae179","volume":"191","author":"YF Li","year":"2024","unstructured":"Li YF, He Y, Yang FY et al (2024) Gasdermin E-mediated keratinocyte pyroptosis participates in the pathogenesis of psoriasis by promoting skin inflammation. Br J Dermatol 191:385\u2013396","journal-title":"Br J Dermatol"},{"key":"2207_CR117","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41419-024-06545-5","volume":"15","author":"F Long","year":"2024","unstructured":"Long F, Wei X, Chen Y et al (2024) Gasdermin E promotes translocation of p65 and c-jun into nucleus in keratinocytes for progression of psoriatic skin inflammation. Cell Death Dis 15:180","journal-title":"Cell Death Dis"},{"key":"2207_CR118","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jid.2016.09.015","volume":"137","author":"J Correa da Rosa","year":"2017","unstructured":"Correa da Rosa J, Kim J, Tian S, Tomalin LE, Krueger JG, Su\u00e1rez-Fari\u00f1as M (2017) Shrinking the psoriasis assessment gap: early gene-expression profiling accurately predicts response to long-term treatment. J Invest Dermatol 137:305\u2013312","journal-title":"J Invest Dermatol"},{"key":"2207_CR119","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.1301737","volume":"192","author":"CB Russell","year":"2014","unstructured":"Russell CB, Rand H, Bigler J et al (2014) Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody. J Immunol 192:3828\u20133836","journal-title":"J Immunol"},{"key":"2207_CR120","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2016.09.001","volume":"167","author":"FL Zhong","year":"2016","unstructured":"Zhong FL, Mamai O, Sborgi L et al (2016) Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation. Cell 167:187","journal-title":"Cell"},{"key":"2207_CR121","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/bjd\/ljad421","volume":"190","author":"L Calabrese","year":"2024","unstructured":"Calabrese L, Fiocco Z, Mellett M et al (2024) Role of the NLRP1 inflammasome in skin cancer and inflammatory skin diseases. Br J Dermatol 190:305\u2013315","journal-title":"Br J Dermatol"},{"key":"2207_CR122","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/ncomms2566","volume":"4","author":"A Walter","year":"2013","unstructured":"Walter A, Sch\u00e4fer M, Cecconi V et al (2013) Aldara activates TLR7-independent immune defence. Nat Commun 4:1560","journal-title":"Nat Commun"},{"key":"2207_CR123","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1007\/s00210-024-03461-5","volume":"398","author":"W Chen","year":"2025","unstructured":"Chen W, Ge L, Zhang C (2025) The molecular mechanism of berberine affecting psoriasis skin inflammation by regulating keratinocyte pyroptosis via the p38 MAPK\/NF-\u03baB pathway. Naunyn Schmiedebergs Arch Pharmacol 398:3843\u20133859","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2207_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1303","volume":"12","author":"J Ma","year":"2024","unstructured":"Ma J, Ji C, Sun Y, Liu D, Pan K, Wei Y (2024) Wogonin ameliorates the proliferation, inflammatory response, and pyroptosis in keratinocytes via NOD-like receptor family pyrin domain containing 3\/Caspase-1\/Gasdermin-D pathway. Immun Inflamm Disease 12:e1303","journal-title":"Immun Inflamm Disease"},{"key":"2207_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114036","volume":"147","author":"S Lai","year":"2025","unstructured":"Lai S, Chen H, Ji X et al (2025) Knockdown of GSDMD inhibits pyroptosis in psoriasis by blocking the NOD-like receptor signaling pathway. Int Immunopharmacol 147:114036","journal-title":"Int Immunopharmacol"},{"key":"2207_CR126","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.jid.2016.02.533","volume":"136","author":"J Hiruma","year":"2016","unstructured":"Hiruma J, Masashi M, Yamamoto M et al (2016) NLRC4 inflammasome is involved in the pathophysiology of psoriasis. J Invest Dermatol 136:S87\u2013S87","journal-title":"J Invest Dermatol"},{"key":"2207_CR127","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/bjd\/ljad455","volume":"190","author":"S Shao","year":"2024","unstructured":"Shao S, Sun ZB, Chu MY et al (2024) Formylpeptide receptor 1 contributes to epidermal barrier dysfunction-induced skin inflammation through NOD-like receptor C4-dependent keratinocyte activation. Br J Dermatol 190:536\u2013548","journal-title":"Br J Dermatol"},{"key":"2207_CR128","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"J Dixon Scott","year":"2012","unstructured":"Dixon Scott J, Lemberg Kathryn M, Lamprecht Michael R et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072","journal-title":"Cell"},{"key":"2207_CR129","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Angeli JPF, Bayir H (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273\u2013285","journal-title":"Cell"},{"key":"2207_CR130","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR (2022) Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185:2401\u20132421","journal-title":"Cell"},{"key":"2207_CR131","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao JY, Dixon SJ (2016) Mechanisms of ferroptosis. Cell Mol Life Sci 73:2195\u20132209","journal-title":"Cell Mol Life Sci"},{"key":"2207_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110108","volume":"127","author":"Y Sun","year":"2020","unstructured":"Sun Y, Chen P, Zhai B et al (2020) The emerging role of ferroptosis in inflammation. Biomed Pharmacother 127:110108","journal-title":"Biomed Pharmacother"},{"key":"2207_CR133","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.bbagen.2018.05.018","volume":"1862","author":"JL Arbiser","year":"2018","unstructured":"Arbiser JL, Bonner MY, Ward N, Elsey J, Rao S (2018) Selenium unmasks protective iron armor: a possible defense against cutaneous inflammation and cancer. Biochim Biophys Acta Gen Subj 1862:2518\u20132527","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"2207_CR134","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00403-024-03345-x","volume":"316","author":"N Wu","year":"2024","unstructured":"Wu N, Hu Q, Fu Z et al (2024) Pilot study of the role of ferroptosis in abnormal biological behaviour of keratinocytes in psoriasis vulgaris. Arch Dermatol Res 316:604","journal-title":"Arch Dermatol Res"},{"key":"2207_CR135","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41419-021-04284-5","volume":"12","author":"Y Shou","year":"2021","unstructured":"Shou Y, Yang L, Yang Y, Xu J (2021) Inhibition of keratinocyte ferroptosis suppresses psoriatic inflammation. Cell Death Dis 12:1009","journal-title":"Cell Death Dis"},{"key":"2207_CR136","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12967-022-03566-6","volume":"20","author":"D Zhang","year":"2022","unstructured":"Zhang D, Li Y, Du C et al (2022) Evidence of pyroptosis and ferroptosis extensively involved in autoimmune diseases at the single-cell transcriptome level. J Transl Med 20:363","journal-title":"J Transl Med"},{"key":"2207_CR137","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.freeradbiomed.2024.09.010","volume":"224","author":"SJ Qian","year":"2024","unstructured":"Qian SJ, Yang ZS, Zhang XY et al (2024) Novel therapeutic approach for psoriasis: upregulating FcRn to inhibit ferroptosis and alleviate lesional skin. Free Radic Biol Med 224:797\u2013808","journal-title":"Free Radic Biol Med"},{"key":"2207_CR138","doi-asserted-by":"publisher","first-page":"e183219","DOI":"10.1172\/JCI183219","volume":"135","author":"K Vats","year":"2024","unstructured":"Vats K, Tian H, Singh K et al (2024) Ferroptosis of select skin epithelial cells initiates and maintains chronic systemic immune-mediated psoriatic disease. J Clin Invest 135:e183219","journal-title":"J Clin Invest"},{"key":"2207_CR139","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1007\/s10753-024-01994-8","volume":"47","author":"L Zhou","year":"2024","unstructured":"Zhou L, Zhong Y, Li C et al (2024) MAPK14 as a key gene for regulating inflammatory response and macrophage M1 polarization induced by ferroptotic keratinocyte in psoriasis. Inflammation 47:1564\u20131584","journal-title":"Inflammation"},{"key":"2207_CR140","first-page":"809","volume":"34","author":"HL Jia","year":"2023","unstructured":"Jia HL, Liu T, Yang QF et al (2023) Tumor-derived PD-L1+exosomes with natural inflammation tropism for psoriasis-targeted treatment. Bioconjug Chem 34:809\u2013824","journal-title":"Bioconjug Chem"},{"key":"2207_CR141","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.jaad.2006.05.004","volume":"55","author":"R Malaviya","year":"2006","unstructured":"Malaviya R, Sun Y, Tan JK et al (2006) Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients. J Am Acad Dermatol 55:590\u2013597","journal-title":"J Am Acad Dermatol"},{"key":"2207_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111897","volume":"41","author":"FP Veras","year":"2022","unstructured":"Veras FP, Publio GA, Melo BM et al (2022) Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation. Cell Rep 41:111897","journal-title":"Cell Rep"},{"key":"2207_CR143","doi-asserted-by":"publisher","first-page":"119689","DOI":"10.1016\/j.bbamcr.2024.119689","volume":"1871","author":"Y Liang","year":"2024","unstructured":"Liang Y, Han D, Zhang S, Sun L (2024) FOSL1 regulates hyperproliferation and NLRP3-mediated inflammation of psoriatic keratinocytes through the NF-kB signaling via transcriptionally activating TRAF3. Biochim Biophys Acta (BBA) 1871:119689","journal-title":"Biochim Biophys Acta (BBA)"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02207-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-025-02207-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-025-02207-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:02:01Z","timestamp":1774000921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-025-02207-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1007\/s10495-025-02207-9","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"26"}}